Companies Partner on Tech for Finding Best Time to Take Medication
Two European pharma companies have teamed up to create a technology platform that will help people with Parkinson’s disease…
Articles by Marisa Wexler, MS
StrivePD App to Monitor Symptoms Via Apple Watch Cleared by FDA
StrivePD, a Rune Labs‘Â app that collects motor symptom data for people with Parkinson’s disease via measurements recorded by…
NeuroString Sensor Measures Neurotransmitter Activity
A soft, stretchable sensor called NeuroString could be used for measuring the activity of neurotransmitters — chemical messengers that nerve…
Synuclein Antibodies Not Useful Parkinson’s Biomarkers: Study
Levels of antibodies against synuclein proteins are lower in people with Parkinson’s disease than in heathy individuals, but these…
Study: Resonance Tube Therapy Improves Speaking Ability
Voice therapy using resonance tubes — glass cylinders partially submerged in water — improved loudness and other vocal parameters in…
Frequent Distressing Dreams Tied to More Than Double Parkinson’s Risk
Men who have distressing dreams more than once a week are at more than two times higher risk of being…
‘Virtual Brain’ Could Lead to More Effective, Personalized DBS Use
Using a personalized “virtual brain” could help in determining the optimal configuration of deep brain stimulation for people with…
Testing P450 Enzyme Activity in Blood May Allow for Early Diagnosis
A blood test that assesses how the activity of a group of enzymes, called P450s, changes when they are blocked could…
STING Protein Drives Inflammation and Neuronal Loss, Study Finds
A protein called STING, which normally helps sense infectious threats like viruses, may help to drive the inflammation that spurs…
Patterns of Brain Atrophy Line Up With Protein’s Damaging Spread
In people with Parkinson’s disease, patterns of brain atrophy over time are consistent with patterns of alpha-synuclein spreading through…